24 related articles for article (PubMed ID: 8871761)
1. Levels of plasma soluble complement receptor 1 (sCR1) in normal Indian adult population.
Sivasankar B; Raju KR; Anand V; Malu S; Padmanabhan S; Tiwari SC; Das N; Srivastava LM
Indian J Clin Biochem; 1999 Jul; 14(2):237-40. PubMed ID: 23105224
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
Walport M; Ng YC; Lachmann PJ
Clin Exp Immunol; 1987 Sep; 69(3):501-7. PubMed ID: 2959411
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies in patients with idiopathic autoimmune haemolytic anemia.
Guzmán J; Cabral AR; Cabiedes J; Pita-Ramirez L; Alarcón-Segovia D
Autoimmunity; 1994; 18(1):51-6. PubMed ID: 7999955
[TBL] [Abstract][Full Text] [Related]
4. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune haemolysis in the dog: relationship between anaemia and the levels of red blood cell bound immunoglobulins and complement measured by an enzyme-linked antiglobulin test.
Barker RN; Gruffydd-Jones TJ; Stokes CR; Elson CJ
Vet Immunol Immunopathol; 1992 Oct; 34(1-2):1-20. PubMed ID: 1441221
[TBL] [Abstract][Full Text] [Related]
6. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
[TBL] [Abstract][Full Text] [Related]
7. Do plasma anti phospholipid antibodies in patients with autoimmune haemolytic anaemia correlate with reduced levels of erythrocyte complement receptor 1?
Jones DR; Scarsbrook AF; Imrie H; Booker D; Sokol RJ
Autoimmunity; 1996; 23(1):45-51. PubMed ID: 8871761
[TBL] [Abstract][Full Text] [Related]
8. Review: complement receptor 1 therapeutics for prevention of immune hemolysis.
Yazdanbakhsh K
Immunohematology; 2005; 21(3):109-18. PubMed ID: 16178668
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune hemolytic anemia.
Izui S
Curr Opin Immunol; 1994 Dec; 6(6):926-30. PubMed ID: 7710716
[TBL] [Abstract][Full Text] [Related]
10. Antigen specificity in canine autoimmune haemolytic anaemia.
Day MJ
Vet Immunol Immunopathol; 1999 Aug; 69(2-4):215-24. PubMed ID: 10507306
[TBL] [Abstract][Full Text] [Related]
11. Complement Receptor 1: disease associations and therapeutic implications.
Khera R; Das N
Mol Immunol; 2009 Feb; 46(5):761-72. PubMed ID: 19004497
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
